Pure Global

Cardiac Resynchronization Therapy Defibrillator - India CDSCO Medical Device Registration

Cardiac Resynchronization Therapy Defibrillator is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2023/000505_0e05a5b37ad597a503bcd7b4d1dd2996_80181496a322bdb5182e48a4018f62e5. This device is marketed under the brand name Fortify Assura DR. The license holder is M/s St. Jude Medical India Pvt. Ltd, and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Cardiac Resynchronization Therapy Defibrillator
UID: IMP/MD/2023/000505_0e05a5b37ad597a503bcd7b4d1dd2996_80181496a322bdb5182e48a4018f62e5

Brand Name

Fortify Assura DR

Device Class

Class D

Approving Authority

CDSCO

Product Information

The Implantable Cardioverter Defibrillator (Fortify Assura DR) devices and Cardiac Resynchronization Therapy Defibrillator (Fortify Assura DR) devices are primarily intended for use with compatible leads to detect and treat life threatening ventricular arrythmias by providing ventricular antitachycardia pacing, and ventricular cardioversion/ defibrillation. In addition, these devices can detect and treat chronic symptomatic bradyarrhythmia by providing sensing and pacing in the right ventricle, and various atrioventricular conduction abnormalities by providing sensing and pacing in the right ventricle and/or the right atrium. CRT-D devices sense cardiac activity and provide pacing to resynchronize the right and left ventricles. ICD devices are indicated in patients who have already survived a cardiac arrest or are at a high risk of Sudden Cardiac Death (Fortify Assura DR) due to VT (Fortify Assura DR) or VF (Fortify Assura DR). The device is most commonly implanted within a device pocket in the pectoral region. Cardiac Resynchronization Therapy (Fortify Assura DR) devices are indicated for reduction of symptoms in patients who have congestive heart failure, a reduced left ventricular ejection fraction (Fortify Assura DR) and a prolonged QRS duration. CRT-D devices are indicated in patients who meet the CRT indications and have already survived a cardiac arrest or are at a high risk of Sudden Cardiac Death (Fortify Assura DR) due to VT (Fortify Assura DR) or VF (Fortify Assura DR). The device is most commonly implanted within a device pocket in the pectoral region.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing